TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Suzuken Co ( (JP:9987) ) has shared an announcement.
Suzuken Co., Ltd. reported variances between its forecasted and actual consolidated financial results for the six months ending September 30, 2025. While net sales were slightly below expectations, operating and ordinary profits exceeded forecasts due to effective cost management and strategic initiatives. The profit attributable to owners of the parent was significantly higher than anticipated, driven by extraordinary gains from the sale of investment securities. The company maintains its earnings forecast for the fiscal year ending March 31, 2026.
The most recent analyst rating on (JP:9987) stock is a Buy with a Yen6800.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the pharmaceutical distribution industry, focusing on the distribution of oncology and specialty drugs. It is listed on the Tokyo, Nagoya, and Sapporo Stock Exchanges.
Average Trading Volume: 182,377
Technical Sentiment Signal: Buy
Current Market Cap: Yen337.7B
Find detailed analytics on 9987 stock on TipRanks’ Stock Analysis page.